Rifabutin
Rifabutin is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Rifabutin; Generic name: RIFABUTIN; Drug class: Rifamycin Antimycobacterial [EPC].
| Brand name | Rifabutin |
|---|---|
| Generic name | RIFABUTIN |
| Drug class | Rifamycin Antimycobacterial [EPC] |
| Manufacturer | A2A Integrated Pharmaceuticals |
| Used for | INDICATIONS AND USAGE Rifabutin capsules are indicated for the prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection. |
| Dosage | DOSAGE AND ADMINISTRATION It is recommended that rifabutin capsules be administered at a dose of 300 mg once daily. For those patients with propensity to nausea, vomiting, or other gastrointestinal upset, administration of rifabutin at doses of 150 mg twice daily taken with food may be useful. Doses of rifabutin may be administered mixed with foods such as applesauce. For patients with severe renal impairment (creatinine clearance less than 30 mL/min), consider reducing the dose of rifabutin by |
| Warnings | WARNINGS Tuberculosis Rifabutin capsules must not be administered for MAC prophylaxis to patients with active tuberculosis. Patients who develop complaints consistent with active tuberculosis while on prophylaxis with rifabutin should be evaluated immediately, so that those with active disease may be given an effective combination regimen of anti-tuberculosis medications. Administration of rifabutin as a single agent to patients with active tuberculosis is likely to lead to the development of tu |
| Active ingredient(s) | RIFABUTIN |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10fb5949-5572-47bd-aaf0-018d9978cad8 |